Study on Association between BMI and Vitamin D Levels in South Indian Rural Population
Abstract
Introduction: Vitamin D deficiency is a global health problem worldwide and is considered to be a pandemic with implications for compromised bone health and other chronic diseases. A few studies have examined the association between vitamin D status and body mass index (BMI). However, prospective data using the biomarker serum 25-hydroxyvitamin D 25(OH) D3 are limited and therefore examined in the present study. This study aims to evaluate the level of vitamin D status among healthy individuals and also to examine the relation between BMI and 25(OH)D in a cross-sectional sample of 100 men and women ranging in age from 18-75 years.
Methods: Participants were selected from subjects attending to Medicine Outpatient Department (OPD) in Sri Venkateshwara Medical College Hospital & Research Centre (SVMCH & RC) willing to participate in the present study between Jan 2020 to Dec 2020. Anthropometric measurements, personal, medical history questionnaire, food frequency questionnaire (FFQ) for vitamin D, and sun exposure questionnaire were collected from all the participants in the present study, blood samples for serum 25(OH)D3 were collected from all subjects.
Results: Our study showed that the majority of healthy individual cases of the study i.e., 68.0% have a deficiency in vitamin D status, while 68.0% have ≤20 ng/dl in vitamin D, and 32.0% in >20 ng/dl. Moreover, the study showed a negative association between the level of circulating 25(OH) D3 and BMI. There is a statistically significant and inverse correlation between the level of circulating 25(OH) D3 and BMI.
Conclusion: This study demonstrated that the association between BMI and 25(OH)D concentrations in populations from south India can be seen across different age groups and in both men and women. The study also exemplified that higher BMI leads to lower vitamin D status, providing evidence for the role of obesity as a causal risk factor for the development of vitamin D deficiency.
Downloads
References
Baskin ML, Ard J, Franklin F, Allison DB. Prevalence of obesity in the United States. Obes Rev. 2005 Feb;6(1):5-7. doi: 10.1111/j.1467-789X.2005.00165.x.
Ogden CL, Carroll MD, Curtin LR, Lamb MM, Flegal KM. Prevalence of high body mass index in US children and adolescents, 2007-2008. JAMA. 2010 Jan 20;303(3):242-9. doi: 10.1001/jama.2009.2012.
Berghöfer A, Pischon T, Reinhold T, Apovian CM, Sharma AM, Willich SN. Obesity prevalence from a European perspective: a systematic review. BMC Public Health. 2008 Jun 5;8:200. doi: 10.1186/1471-2458-8-200.
Zheng W, McLerran DF, Rolland B, Zhang X, Inoue M, Matsuo K, et al. Association between body-mass index and risk of death in more than 1 million Asians. N Engl J Med. 2011 Feb 24;364(8):719-29. doi: 10.1056/NEJMoa1010679.
Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA. 2012 Feb 1;307(5):491-7. doi: 10.1001/jama.2012.39.
Vimaleswaran KS, Loos RJ. Progress in the genetics of common obesity and type 2 diabetes. Expert Rev Mol Med. 2010 Feb 26;12:e7. doi: 10.1017/S1462399410001389.
Ginde AA, Liu MC, Camargo CA Jr. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med. 2009 Mar 23;169(6):626-32. doi: 10.1001/archinternmed.2008.604.
Lanham-New SA, Buttriss JL, Miles LM, Ashwell M, Berry JL, Boucher BJ, et al. Proceedings of the Rank Forum on Vitamin D. Br J Nutr. 2011 Jan;105(1):144-56. doi: 10.1017/S0007114510002576.
Hyppönen E, Power C. Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr. 2007 Mar;85(3):860-8. doi: 10.1093/ajcn/85.3.860.
Earthman CP, Beckman LM, Masodkar K, Sibley SD. The link between obesity and low circulating 25-hydroxyvitamin D concentrations: considerations and implications. Int J Obes (Lond). 2012 Mar;36(3):387-96. doi: 10.1038/ijo.2011.119.
Shi H, Norman AW, Okamura WH, Sen A, Zemel MB. 1alpha,25-Dihydroxyvitamin D3 modulates human adipocyte metabolism via nongenomic action. FASEB J. 2001 Dec;15(14):2751-3. doi: 10.1096/fj.01-0584fje.
Fassina G, Maragno I, Dorigo P, Contessa AR. Effect of vitamin D2 on hormone-stimulated lipolysis in vitro. Eur J Pharmacol. 1969 Feb;5(3):286-90. doi: 10.1016/0014-2999(69)90150-2.
Sneve, M., Y. Figenschau, and R. Jorde. "Supplementation with cholecalciferol does not result in weight reduction in overweight and obese subjects." European journal of endocrinology 159.6 (2008): 675-684.
Zittermann A, Frisch S, Berthold HK, Götting C, Kuhn J, Kleesiek K, et al. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr. 2009 May;89(5):1321-7. doi: 10.3945/ajcn.2008.27004.
Salehpour A, Shidfar F, Hosseinpanah F, Vafa M, Razaghi M, Hoshiarrad A, Gohari M. Vitamin D3 and the risk of CVD in overweight and obese women: a randomised controlled trial. Br J Nutr. 2012 Nov 28;108(10):1866-73. doi: 10.1017/S0007114512000098.
Soares MJ, Murhadi LL, Kurpad AV, Chan She Ping-Delfos WL, Piers LS. Mechanistic roles for calcium and vitamin D in the regulation of body weight. Obes Rev. 2012 Jul;13(7):592-605. doi: 10.1111/j.1467-789X.2012.00986.x.
Foss YJ. Vitamin D deficiency is the cause of common obesity. Med Hypotheses. 2009 Mar;72(3):314-21. doi: 10.1016/j.mehy.2008.10.005.
Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000 Sep;72(3):690-3. doi: 10.1093/ajcn/72.3.690.
Davey Smith G. Random allocation in observational data: how small but robust effects could facilitate hypothesis-free causal inference. Epidemiology. 2011 Jul;22(4):460-3; discussion 467-8. doi: 10.1097/EDE.0b013e31821d0426.
Palmer TM, Lawlor DA, Harbord RM, Sheehan NA, Tobias JH, Timpson NJ, et al. Using multiple genetic variants as instrumental variables for modifiable risk factors. Stat Methods Med Res. 2012 Jun;21(3):223-42. doi: 10.1177/0962280210394459.
Jorde R, Sneve M, Emaus N, Figenschau Y, Grimnes G. Cross-sectional and longitudinal relation between serum 25-hydroxyvitamin D and body mass index: the Tromsø study. Eur J Nutr. 2010 Oct;49(7):401-7. doi: 10.1007/s00394-010-0098-7.
Lee P, Greenfield JR, Seibel MJ, Eisman JA, Center JR. Adequacy of vitamin D replacement in severe deficiency is dependent on body mass index. Am J Med. 2009 Nov;122(11):1056-60. doi: 10.1016/j.amjmed.2009.06.008.
Bassett DR Jr, Pucher J, Buehler R, Thompson DL, Crouter SE. Walking, cycling, and obesity rates in Europe, North America, and Australia. J Phys Act Health. 2008 Nov;5(6):795-814. doi: 10.1123/jpah.5.6.795.
Drincic AT, Armas LA, Van Diest EE, Heaney RP. Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity (Silver Spring). 2012 Jul;20(7):1444-8. doi: 10.1038/oby.2011.404.
Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000 Sep;72(3):690-3. doi: 10.1093/ajcn/72.3.690.
Copyright (c) 2021 Author (s). Published by Siddharth Health Research and Social Welfare Society
This work is licensed under a Creative Commons Attribution 4.0 International License.